Covington Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$11K Hold
438
﹤0.01% 812
2022
Q2
$15K Buy
438
+88
+25% +$3.74K ﹤0.01% 759
2022
Q1
$25K Buy
350
+252
+257% +$18.2K ﹤0.01% 686
2021
Q4
$9K Sell
98
-12,718
-99% -$1.52M ﹤0.01% 799
2021
Q3
$1.63M Sell
12,816
-275
-2% -$40K 0.06% 197
2021
Q2
$2.18M Sell
13,091
-47
-0.4% -$7.62K 0.09% 178
2021
Q1
$2.39M Buy
13,138
+150
+1% +$34.8K 0.1% 162
2020
Q4
$2.6M Buy
12,988
+428
+3% +$87K 0.12% 154
2020
Q3
$2.75M Buy
12,560
+475
+4% +$101K 0.14% 143
2020
Q2
$2.31M Buy
12,085
+9,830
+436% +$1.72M 0.13% 143
2020
Q1
$350K Buy
2,255
+2,200
+4,000% +$256K 0.02% 248
2019
Q4
$5K Hold
55
﹤0.01% 783
2019
Q3
$4K Hold
55
﹤0.01% 751
2019
Q2
$4K Hold
55
﹤0.01% 734
2019
Q1
$3K Hold
55
﹤0.01% 700
2018
Q4
$3K Hold
55
﹤0.01% 707
2018
Q3
$5K Hold
55
﹤0.01% 650
2018
Q2
$3K Buy
+55
New +$2.69K ﹤0.01% 681

Other funds holding TDOC

Covington Capital Management's TDOC Position: Q3 2022 in Review

Covington Capital Management held its Teladoc Health (TDOC) position steady in Q3 2022 at 438 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Covington Capital Management first reported a position in TDOC in Q2 2018 and has held it in 18 quarters since. The position peaked at $2.75M in Q3 2020. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Covington Capital Management held 438 shares of Teladoc Health worth $11K as of Q3 2022.
  • Covington Capital Management left its Teladoc Health share count unchanged in Q3 2022.
  • Teladoc Health made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #812 holding.
  • Covington Capital Management first reported a position in Teladoc Health in Q2 2018 and has held it in 18 quarters since.
  • Covington Capital Management's Teladoc Health position peaked at $2.75M in Q3 2020.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.